Clinical Trials

VGI Health Technology Limited (NSX:VTL) Binding Sale Agreement of Subsidiary

🕔4/6/2022 8:50:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) US Divisional Patent to be Granted

🕔4/4/2022 7:44:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the 'Transmucosal Delivery of Tocotrienols' to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) to Present at American Society for Nutrition Conference

🕔3/21/2022 8:57:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Executes Agreement with Continuum Sciences LLC

🕔2/25/2022 9:02:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Dr Moon to present at Experimental Biology Conference

🕔2/23/2022 8:36:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Term Sheet for Sale of Invictus BioPharma Group

🕔2/14/2022 9:09:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Approval of New Clinical Study Site

🕔2/9/2022 9:05:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned subsidiary, Invictus Ops Pty Ltd, has received Human Research Ethics Committee (HREC) approval from a Lead Ethics Committee Site, Bellberry Ltd, for a Phase II clinical study on Non-Alcoholic Fatty Liver Disease.

Read Full Article